HDAC9 and asthma: More than 350 clinical trials involving HDAC inhibitors (https://www.clinicaltrials.gov/) have been carried out or are ongoing against various diseases, including cancers, Alzheimer’s disease, schizophrenia, asthma, and chronic obstructive pulmonary disease (COPD).